Ignite Creation Date:
2024-05-06 @ 2:45 AM
Last Modification Date:
2024-10-26 @ 11:22 AM
Study NCT ID:
NCT02115295
Status:
RECRUITING
Last Update Posted:
2024-04-25
First Post:
2014-04-14
Brief Title:
Cladribine Idarubicin Cytarabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia High-Risk Myelodysplastic Syndrome or Blastic Phase Chronic Myeloid Leukemia
Sponsor:
Organization:
MD Anderson Cancer Center